Should I stop taking Elavil (amitriptyline) because I have a right bundle branch block on my ECG?

Should You Stop Elavil (Amitriptyline) in a Patient with Right Bundle Branch Block?

No, you should not automatically stop amitriptyline in a patient with isolated right bundle branch block (RBBB), but you must carefully assess for additional conduction abnormalities and symptoms that would indicate higher risk. 1

Risk Stratification Algorithm

Proceed with amitriptyline if:

• Isolated RBBB with normal PR interval and no symptoms of bradycardia or syncope 1
• No evidence of bifascicular block (RBBB plus left anterior or posterior fascicular block) 1
• No alternating bundle branch block pattern 1

Exercise extreme caution or discontinue if:

• Bifascicular block with syncope is present, as the mechanism may be intermittent complete heart block rather than a rhythm amenable to continued tricyclic therapy 1
• Alternating bundle branch block is documented, which indicates unstable trifascicular disease with high risk of complete heart block 1, 2
• Sick sinus syndrome or symptomatic bradycardia coexists with the bundle branch block 1
• Prolonged PR interval (first-degree AV block) accompanies the RBBB 3

Evidence-Based Rationale

The critical distinction is between isolated RBBB versus RBBB with additional conduction system disease. Amitriptyline, like all tricyclic antidepressants, has quinidine-like effects that slow cardiac conduction, particularly through the His-Purkinje system. 4

Key clinical data:

• In a prospective study of 196 depressed patients, the prevalence of second-degree atrioventricular block was significantly greater in patients with preexisting bundle-branch block (9%) compared to those with normal ECGs (0.7%) when treated with therapeutic concentrations of tricyclic antidepressants 4
• A case report documented bilateral bundle branch block during amitriptyline treatment, where incomplete left bundle branch block was masked by complete RBBB and left anterior fascicular block, resulting in syncope 2

Practical Management Steps

Immediate assessment required:

1. Obtain a 12-lead ECG to evaluate for bifascicular block (RBBB plus left anterior or posterior hemiblock) 3
2. Measure the PR interval precisely—first-degree AV block (PR >200 ms) combined with RBBB increases risk 3
3. Review any prior ECGs to determine if the RBBB is new or longstanding, and whether alternating bundle branch block has occurred 1, 2
4. Elicit history of syncope, presyncope, or bradycardia symptoms 3

If bifascicular block with syncope is identified:

• Refer for electrophysiology study before continuing amitriptyline, as syncope may indicate intermittent complete heart block 1
• Consider alternative antidepressant therapy with less cardiac conduction effects (SSRIs, SNRIs) 4

If isolated RBBB without additional risk factors:

• Continue amitriptyline with close monitoring 1
• Consider ambulatory ECG monitoring if any symptoms develop to detect intermittent AV block 3

Common Pitfalls to Avoid

Do not confuse bundle branch block with AV block. Amitriptyline primarily affects AV nodal conduction and His-Purkinje conduction, not the bundle branches themselves. 1 However, in patients with pre-existing bundle branch disease, the additional conduction slowing can unmask or precipitate complete heart block. 4

Do not assume all syncope in bundle branch block patients is vasovagal. The true mechanism may be intermittent complete heart block, which amitriptyline could worsen. 1 This requires electrophysiologic evaluation rather than empiric continuation of therapy.

Do not overlook the significance of bifascicular block. RBBB combined with left anterior or posterior fascicular block indicates disease in two of the three fascicles, leaving only one functioning pathway. 1, 3 Adding a conduction-slowing drug like amitriptyline in this setting substantially increases the risk of complete heart block.